PT Murni Sadar Tbk (MTMH.JK)
IDR 980.0
(-2.49%)
IDR 980.0
(-2.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -12.83 Billion IDR | -119.46% |
| 2022 | 65.95 Billion IDR | -49.41% |
| 2021 | 130.36 Billion IDR | 5118.18% |
| 2020 | 2.49 Billion IDR | 102.92% |
| 2019 | -85.6 Billion IDR | -913.96% |
| 2018 | -8.44 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 7.51 Billion IDR | 70.71% |
| 2024 Q2 | 4.39 Billion IDR | -37.21% |
| 2024 Q1 | 7 Billion IDR | 154.11% |
| 2023 Q2 | -13.68 Billion IDR | -383.21% |
| 2023 Q3 | 8.97 Billion IDR | 165.56% |
| 2023 Q4 | -12.95 Billion IDR | -244.37% |
| 2023 Q1 | 4.83 Billion IDR | -81.43% |
| 2023 FY | -12.83 Billion IDR | -119.46% |
| 2022 FY | 65.95 Billion IDR | -49.41% |
| 2022 Q4 | 26.01 Billion IDR | 2007.58% |
| 2022 Q2 | 6.8 Billion IDR | -78.65% |
| 2022 Q1 | 31.9 Billion IDR | 151.43% |
| 2022 Q3 | 1.23 Billion IDR | -81.88% |
| 2021 Q1 | 73.73 Billion IDR | 0.0% |
| 2021 Q3 | 44.91 Billion IDR | -39.09% |
| 2021 Q2 | 73.73 Billion IDR | 0.0% |
| 2021 FY | 130.36 Billion IDR | 5118.18% |
| 2021 Q4 | -62.02 Billion IDR | -238.1% |
| 2020 FY | 2.49 Billion IDR | 102.92% |
| 2019 FY | -85.6 Billion IDR | -913.96% |
| 2018 FY | -8.44 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Bundamedik Tbk | 7.46 Billion IDR | 271.982% |
| PT Metro Healthcare Indonesia Tbk | -110.91 Billion IDR | 88.431% |
| PT Medikaloka Hermina Tbk | 437.34 Billion IDR | 102.934% |
| PT Mitra Keluarga Karyasehat Tbk | 916.13 Billion IDR | 101.401% |
| PT Famon Awal Bros Sedaya Tbk | 216.97 Billion IDR | 105.914% |
| PT Royal Prima Tbk | -2.74 Billion IDR | -367.205% |
| PT Kedoya Adyaraya Tbk | 25.18 Billion IDR | 150.942% |
| PT Sarana Meditama Metropolitan Tbk | 12.25 Billion IDR | 204.73% |
| PT Siloam International Hospitals Tbk | 1211.28 Billion IDR | 101.059% |
| PT Sejahteraraya Anugrahjaya Tbk | -38.49 Billion IDR | 66.662% |